Acrivon Therapeutics (ACRV) Capital Expenditures (2021 - 2026)
Acrivon Therapeutics (ACRV) reported Capital Expenditures of $87,000 for Q2 2026, down 82.4% from $493,000 a year earlier but up 521.4% from the prior quarter.
Powered by 
Analysis
Acrivon Therapeutics (ACRV) Capital Expenditures (2021 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Acrivon Therapeutics' Capital Expenditures came in at $1.22 million, down 48.5% year-over-year; for FY2025, it came in at $1.67 million, down 39.7% from FY2024.
- Capital Expenditures has a four-year compound annual growth rate of 62.7% (FY2021 to FY2025).
- By year, Capital Expenditures came in at $2.77 million in FY2024 (+114.9%), $1.29 million in FY2023 (-40.5%), $2.17 million in FY2022 (+810.1%) and $238,000 in FY2021.
- Five-year quarterly Capital Expenditures spans a low of $14,000 in Q1 2026 and a high of $1.15 million in Q4 2023.
- Year over year, Capital Expenditures has now declined in each of the last four quarters, with an average decline of 14.6% over the last seven quarters.
- The high point for year-over-year Capital Expenditures in five years was Q4 2023 (growth of 358.6%); the low point was Q1 2023 (a decline of 94.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $14,000 (Q1 2026), $219,000 (Q4 2025) and $899,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Acrivon Therapeutics | 87.84 Mn | 87.84 Mn | - | 87,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 87,000.00 |
| Mar 31, 2026 | 14,000.00 |
| Dec 31, 2025 | 219,000.00 |
| Sep 30, 2025 | 899,000.00 |
| Jun 30, 2025 | 493,000.00 |
| Mar 31, 2025 | 58,000.00 |
| Dec 31, 2024 | 827,000.00 |
| Sep 30, 2024 | 989,000.00 |
| Jun 30, 2024 | 137,000.00 |
| Mar 31, 2024 | 815,000.00 |
| Dec 31, 2023 | 1.15 Mn |
| Jun 30, 2023 | 112,000.00 |
| Mar 31, 2023 | 25,000.00 |
| Dec 31, 2022 | 251,000.00 |
| Sep 30, 2022 | 426,000.00 |
| Jun 30, 2022 | 1.07 Mn |
| Mar 31, 2022 | 415,000.00 |
| Dec 31, 2021 | 137,000.00 |
API Access
Acrivon Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ACRV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "ACRV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ACRV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();